It is very easy to throw stones in this circumstance, but to really throw a stone, you need to look at all the facts and then see where the alternative path was going to take you.
Some are saying that the company should have launched every trial under the sun 2 years ago.
We know FDA agreement for CLBP, and the following trial design has only just completed late last year, into this year. So they could have started maybe 3 months ago, and be down to 50 mill in the bank.
We also know the FDA would not let Mesoblast initiate another trial until the potency assay was agreed with them, and it's only just been agreed by FDA?
So had we started an adult trial 2 years ago with the unacceptable potency assay, all that would have happened is a cash burning exercise.
What are the alternatives, and how do you expect they would have been funded.
MSB Price at posting:
47.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)